Drug-eluting stent thrombosis in the treatment of chronic total coronary occlusions: Incidence, presentation and related factors. Data from the CIBELES trial
Author(s) -
Eduardo Arroyo,
Raúl Moreno,
Eulogio Garcı́a,
Rui Campante Teles,
José Ramón Rumoroso,
Henrique Carvalho,
Francisco Javier Goicolea,
José Moreu,
Josefa Mauri,
Manel Sabaté,
Vicente Mainar,
Lino Patrício,
Mariano Valdés,
Felipe FernándezVázquez,
Ángel SánchezRecalde,
Guillermo Galeote,
Santiago JiménezValero,
Manuel Almeida,
Esteban López de Sá,
Luís Calvo,
Ignacio Plaza,
J L López-Sendón,
Jose-Luis R. Martín
Publication year - 2015
Publication title -
revista portuguesa de cardiologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.266
H-Index - 26
eISSN - 2174-2030
pISSN - 0870-2551
DOI - 10.1016/j.repc.2014.08.026
Subject(s) - medicine , thrombosis , stent , myocardial infarction , univariate analysis , sirolimus , incidence (geometry) , everolimus , cardiology , surgery , multivariate analysis , physics , optics
The aim of this study was to analyze the incidence of drug-eluting stent thrombosis (sirolimus or everolimus) in patients with chronic total coronary occlusions (CTO) and to determine its clinical implications and related factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom